S

Sarepta Therapeutics
D

SRPT

62.490
USD
0.61
(0.99%)
Market Closed
Volume
129,683
EPS
8
Div Yield
-
P/E
25
Market Cap
6,063,534,242
Related Instruments
AMGN
AMGN
-1.12
(-0.37%)
305.62 USD
BIIB
BIIB
-0.710
(-0.54%)
131.320 USD
BMRN
BMRN
0.380
(0.56%)
68.300 USD
GILD
GILD
0.670
(0.60%)
111.930 USD
INCY
INCY
1.415
(2.32%)
62.320 USD
I
IONS
1.455
(5.34%)
28.715 USD
R
RCKT
0.49000
(8.44%)
6.29500 USD
REGN
REGN
8.56
(1.39%)
625.24 USD
VRTX
VRTX
-1.36
(-0.28%)
483.38 USD
More
News

Title: Sarepta Therapeutics

Sector: Healthcare
Industry: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.